The market growth of antibiotics can be attributed to factors, such as increasing incidents of infectious diseases such as diarrhea, pneumonia, malaria, tuberculosis, and others. This leads to an increased demand for antibiotics production. According to UNICEF, in 2017, diarrhea accounted for approximately 8 percent of all deaths among children under the age of 5 worldwide. Furthermore, increasing investments in R&D by major biopharmaceutical companies are also leading to market growth.
The Antibiotics Market is segmented on the basis of product Drug Class, Applications, Route of Administration, and region.
Major Drug Class of Antibiotics Market covered are:
- Beta-lactams
- Macrolides
- Aminoglycosides
- Quinolones
Major Route of Administration of Antibiotics Market covered are:
- Oral
- Intravenous
Major Applications of Antibiotics Market covered are:
- Retail Pharmacies
- Online Pharmacies
Other factors, such as supportive government policies, are expected to provide lucrative growth opportunities for the market. For instance, the U.S. government enacted the Generating Antibiotic Incentives Now Act (GAIN Act) of 2012, which provides benefits to manufacturers of Qualified Infectious Disease Products (QIDPs) including 5 years of additional non patent exclusivity. Moreover, technological advancements in the development of innovative drugs by the key players will also boost market growth.
No comments:
Post a Comment